NCT00135213
- Conditions
- Behavior, Health Behavior, Health Care Quality, Access, and Evaluation, +1 more
- Locations
-
- University of Rochester Rochester, New York, United States
Clinical trial condition
Smoking Cessation
Explore clinical trials studying Smoking Cessation. Study availability and eligibility vary by location and protocol.
912 public trials
85 recruiting studies
Smoking Cessation trial results
NCT00143364
- Conditions
- Behavior, Health Behavior, Smoking Cessation
- Locations
-
- Pfizer Investigational Site Palo Alto, California, United States
- Pfizer Investigational Site San Diego, California, United States
- Pfizer Investigational Site Denver, Colorado, United States
- Pfizer Investigational Site Pembroke Pines, Florida, United States
Completed
An Open Label Study That Compares Varenicline to Transdermal Nicotine Patch for Smoking Cessation
NCT00143325
- Conditions
- Behavior, Health Behavior, Smoking Cessation
- Locations
-
- Pfizer Investigational Site Palo Alto, California, United States
- Pfizer Investigational Site Santa Ana, California, United States
- Pfizer Investigational Site Farmington, Connecticut, United States
- Pfizer Investigational Site Lexington, Kentucky, United States
NCT00141206
- Conditions
- Behavior, Health Behavior, Smoking Cessation
- Locations
-
- Pfizer Investigational Site Tucson, Arizona, United States
- Pfizer Investigational Site Los Angeles, California, United States
- Pfizer Investigational Site Newport Beach, California, United States
- Pfizer Investigational Site Riverside, California, United States
NCT00150254
- Conditions
- Behavior, Health Behavior, Smoking Cessation
- Locations
-
- Pfizer Investigational Site Los Angeles, California, United States
- Pfizer Investigational Site San Bernardino, California, United States
- Pfizer Investigational Site Upland, California, United States
- Pfizer Investigational Site West Covina, California, United States
NCT00143286
- Conditions
- Behavior, Health Behavior, Smoking Cessation
- Locations
-
- Pfizer Investigational Site Santa Ana, California, United States
- Pfizer Investigational Site West Palm Beach, Florida, United States
- Pfizer Investigational Site Lexington, Kentucky, United States
- Pfizer Investigational Site Mogadore, Ohio, United States
NCT00139750
- Conditions
- Behavior, Health Behavior, Smoking Cessation
- Locations
-
- Pfizer Investigational Site Noda, Chiba, Japan
- Pfizer Investigational Site Fukuoka, Japan
- Pfizer Investigational Site Sapporo, Hokkaido, Japan
- Pfizer Investigational Site Yokohama, Kanagawa, Japan
NCT00150228
- Conditions
- Behavior, Health Behavior, Smoking Cessation
- Locations
-
- Pfizer Investigational Site Lexington, Kentucky, United States
- Pfizer Investigational Site Albert Lea, Minnesota, United States
- Pfizer Investigational Site Rochester, Minnesota, United States
- Pfizer Investigational Site Philadelphia, Pennsylvania, United States
NCT00143299
- Conditions
- Behavior, Health Behavior, Smoking Cessation
- Locations
-
- Pfizer Investigational Site Denver, Colorado, United States
- Pfizer Investigational Site Milford, Massachusetts, United States
- Pfizer Investigational Site Albuquerque, New Mexico, United States
- Pfizer Investigational Site Syracuse, New York, United States
NCT00475046
- Conditions
- Behavior, Health Behavior, Smoking, +1 more
- Locations
-
Not specified